Unknown

Dataset Information

0

Populations and Interventions for Palliative and End-of-Life Care: A Systematic Review.


ABSTRACT:

Importance

Evidence supports palliative care effectiveness. Given workforce constraints and the costs of new services, payers and providers need help to prioritize their investments. They need to know which patients to target, which personnel to hire, and which services best improve outcomes.

Objective

To inform how payers and providers should identify patients with "advanced illness" and the specific interventions they should implement, we reviewed the evidence to identify (1) individuals appropriate for palliative care and (2) elements of health service interventions (personnel involved, use of multidisciplinary teams, and settings of care) effective in achieving better outcomes for patients, caregivers, and the healthcare system.

Evidence review

Systematic searches of MEDLINE, EMBASE, PsycINFO, Web of Science, and Cochrane Database of Systematic Reviews databases (1/1/2001-1/8/2015).

Results

Randomized controlled trials (124) met inclusion criteria. The majority of studies in cancer (49%, 38 of 77 studies) demonstrated statistically significant patient or caregiver outcomes (e.g., p?ConclusionsPalliative care improves cancer, CHF, COPD, and dementia outcomes. Effective models include nurses, social workers, and home-based components, and a focus on communication, psychosocial support, and the patient or caregiver experience. High-quality research on intervention costs and cost outcomes in palliative care is limited.

SUBMITTER: Singer AE 

PROVIDER: S-EPMC5011630 | biostudies-literature | 2016 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Importance</h4>Evidence supports palliative care effectiveness. Given workforce constraints and the costs of new services, payers and providers need help to prioritize their investments. They need to know which patients to target, which personnel to hire, and which services best improve outcomes.<h4>Objective</h4>To inform how payers and providers should identify patients with "advanced illness" and the specific interventions they should implement, we reviewed the evidence to identify (1) in  ...[more]

Similar Datasets

| S-EPMC8419069 | biostudies-literature
| S-EPMC9207918 | biostudies-literature
| S-EPMC10790406 | biostudies-literature
| S-EPMC8024379 | biostudies-literature
| S-EPMC6020769 | biostudies-literature
| S-EPMC8485198 | biostudies-literature
| S-EPMC7259853 | biostudies-literature
| S-EPMC9614729 | biostudies-literature
| S-EPMC11348222 | biostudies-literature